methylphenidate has been researched along with Developmental Psychomotor Disorders in 9 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The reviewed studies support the use of methylphenidate to improve end-of-life patient cognitive functions, particularly in the case of hypoactive delirium." | 4.86 | [Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: A literature review]. ( Elie, D; Gagnon, B; Gagnon, P; Giguère, A, 2010) |
| "Probably pseudohypoaldosteronism was a coincidental finding in this girl with a CDK13 mutation, but because only limited information is known about CDK13-related disorders, further investigation could be more informative to clarify this presentation." | 2.61 | One-month-old girl presenting with pseudohypoaldosteronism leading to the diagnosis of CDK13-related disorder: a case report and review of the literature. ( Ayman, A; Kremer, AK; van den Akker, M; Yakubov, R, 2019) |
| "A patient with advanced pancreatic cancer is presented to demonstrate the clinical challenge of diagnosing depression in palliative care." | 1.31 | Depression with psychomotor retardation: diagnostic challenges and the use of psychostimulants. ( Bruera, E; Pereira, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yakubov, R | 1 |
| Ayman, A | 1 |
| Kremer, AK | 1 |
| van den Akker, M | 1 |
| Elie, D | 1 |
| Gagnon, P | 1 |
| Gagnon, B | 1 |
| Giguère, A | 1 |
| Harvey, WJ | 1 |
| Reid, G | 1 |
| Grizenko, N | 1 |
| Mbekou, V | 1 |
| Ter-Stepanian, M | 1 |
| Joober, R | 1 |
| Bridgeford, D | 1 |
| Arciniegas, DB | 1 |
| Batkis, M | 1 |
| Sandberg, E | 1 |
| Beresford, TP | 1 |
| Volkow, ND | 1 |
| Chang, L | 1 |
| Wang, GJ | 1 |
| Fowler, JS | 1 |
| Leonido-Yee, M | 1 |
| Franceschi, D | 1 |
| Sedler, MJ | 1 |
| Gatley, SJ | 1 |
| Hitzemann, R | 1 |
| Ding, YS | 1 |
| Logan, J | 1 |
| Wong, C | 1 |
| Miller, EN | 1 |
| Pereira, J | 1 |
| Bruera, E | 1 |
| Satterfield, JH | 1 |
| Peters, JE | 1 |
| Milner, G | 1 |
2 reviews available for methylphenidate and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
One-month-old girl presenting with pseudohypoaldosteronism leading to the diagnosis of CDK13-related disorder: a case report and review of the literature.
Topics: CDC2 Protein Kinase; Chelating Agents; DNA Mutational Analysis; Female; Humans; Infant; Intellectual | 2019 |
[Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: A literature review].
Topics: Aged; Caffeine; Central Nervous System Stimulants; Cognition Disorders; Confusion; Delirium; Depress | 2010 |
7 other studies available for methylphenidate and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Fundamental movement skills and children with attention-deficit hyperactivity disorder: peer comparisons and stimulant effects.
Topics: Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Central Nervous System Stimulan | 2007 |
Methylphenidate treatment of neuropsychiatric symptoms of central and extrapontine myelinolysis.
Topics: Alcoholism; Central Nervous System Stimulants; Chronic Disease; Corpus Striatum; Humans; Magnetic Re | 2000 |
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
Topics: Adult; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Caudate Nucleus; Cerebellum; | 2001 |
Depression with psychomotor retardation: diagnostic challenges and the use of psychostimulants.
Topics: Aged; Central Nervous System Stimulants; Depression; Humans; Male; Methylphenidate; Palliative Care; | 2001 |
EEG issues in children with minimal brain dysfunction.
Topics: Acoustic Stimulation; Attention Deficit Disorder with Hyperactivity; Child; Diagnosis, Differential; | 1973 |
Minimal brain dysfunctions in children.
Topics: Amphetamine; Attention; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Comm | 1974 |
Interaction between barbiturates, alcohol and some psychotropic drugs.
Topics: Adolescent; Adult; Alcoholic Intoxication; Amitriptyline; Animals; Antidepressive Agents; Automobile | 1970 |